A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
ITM Solucin GmbH
National Cancer Institute (NCI)
Fudan University
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
M.D. Anderson Cancer Center
Neotropix